• Proposed Re-evaluation Decision PRVD2021-03, Florasulam and Its Associated End-use Products
• Proposed Re-evaluation Decision PRVD2021-06, Difenoconazole and Its Associated End-use Products
• Proposed Re-evaluation Decision PRVD2021-02, Isoxaflutole and Its Associated End-use Products
• Proposed Re-evaluation Decision PRVD2021-05, Triticonazole and Its Associated End-use Products
• Proposed Re-evaluation Decision PRVD2021-10, Ancymidol and Its Associated End-use Products